Twist Bioscience Form 144: Patrick Finn plans $90K stock sale

Rhea-AI Filing Summary

Twist Bioscience Corporation (TWST) has filed a Form 144 notice covering the potential sale of 3,189 common shares through Fidelity Brokerage, with an estimated market value of $90,453. The proposed trade window opens on 04 Aug 2025. The company reports 59,916,141 shares outstanding, so the planned sale represents roughly 0.005 % of the float—immaterial at the corporate level.

The shares derive from restricted-stock that vested on 01 Aug 2025 and are held in the account of Patrick Finn. Over the previous three months, Finn has already sold 27,118 shares for total gross proceeds of $894,853, indicating an ongoing disposition program.

Form 144 is only a notice; execution, timing, and price may vary, and the filer certifies no undisclosed material adverse information. No operating, earnings or guidance data accompany this filing.

Positive

• None.

Negative

• Continued insider selling: 27,118 shares sold in the last 3 months plus a new notice for 3,189 shares may signal reduced insider exposure.

Insights

Financial Analyst

TL;DR: Small Form 144 (<0.01 % float) suggests routine insider liquidity, not a material overhang.

The proposed 3,189-share sale is valued at just $90k and, even combined with the prior 27k shares sold since May, remains negligible versus TWST’s 60 m share base. Such filings are common following restricted-stock vesting and do not necessarily indicate negative sentiment. However, the continued sales show this insider is monetizing holdings, which some investors interpret cautiously. No financial metrics or strategic disclosures are included, so the impact on valuation is minimal.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3189	90453.11	59916141	08/04/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2025	Restricted Stock Vesting	Issuer			3189	08/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	05/05/2025	2800	105422.80
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	05/08/2025	20000	646256.55
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	05/21/2025	1877	55835.87
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	07/02/2025	209	7564.36
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	07/23/2025	2232	79773.02

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Twist Bioscience (TWST) shares are covered by this Form 144?

3,189 common shares are eligible for sale under the notice.

What is the approximate dollar value of the proposed TWST share sale?

Based on the filing, the sale is valued at $90,453.

When can the insider begin selling the TWST shares?

The filing lists an approximate sale date of 08/04/2025.

How many TWST shares has the filer sold in the past three months?

A total of 27,118 shares were sold, generating $894,853 in gross proceeds.

Does a Form 144 guarantee that the insider will sell the shares?

No. Form 144 is a notice of intent; actual sales may differ in timing or quantity.